Good day, everyone, and welcome to today's Flexible Solutions International Second Quarter 2025 Financials Conference Call. [Operator Instructions] Please note, this call is being recorded, and I will ...

Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...

HighPeak Energy has strengthened its finances, addressing its debt position. Read more on what this may mean for an ...

Micron reports record Q3 FY2025 revenue of $9.30B, driven by DRAM and HBM growth. Discover insights into their unique ...

The US path to a much anticipated rate cut was well-drawn, particularly after Tuesday's CPI report coming along the Fed's ...

Claritev shows revenue growth & client wins, but extreme leverage & legal risks raise concerns. Insider buying adds ...

XXRP offers 2x daily XRP exposure. Learn why this ETF needs to be handled with extreme caution and doesn't suit long-term ...

Eli Lilly insiders made notable stock purchases in August, but competitive pressures and pricing risks make me question its ...

Navigate S&P 500 volatility with SDS, a 2x leveraged inverse ETF ideal for short-term trades amidst market catalysts. Click ...

OpenAI employees and former staffers apparently plan to sell up to $6B worth of shares to an investor group, which will propel the company's valuation to a staggering $500B, according to Bloomberg.

Berkshire Hathaway’s UnitedHealth Group Incorporated investment highlights confidence in healthcare. Click for why I am ...

The Vanguard FTSE Developed Markets ETF (NYSEARCA: VEA) is one of the most popular ETFs in the world for gaining exposure to ...